Cytarabine and Clofarabine in Treating Patients With Refractory or Relapsed Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia

NCT00295841 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

53

Enrollment

OTHER

Sponsor class

Conditions

Leukemia

Interventions

DRUG: clofarabine
DRUG: cytarabine

Sponsor

Wake Forest University Health Sciences

Collaborators

[object Object]